MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

A (medicines beginning with A) B (medicines beginning with B) C (medicines beginning with C) D (medicines beginning with D) E (medicines beginning with E) F (medicines beginning with F) G (medicines beginning with G) H (medicines beginning with H) I (medicines beginning with I) K (medicines beginning with K) L (medicines beginning with L) M (medicines beginning with M) N (medicines beginning with N) O (medicines beginning with O) P (medicines beginning with P) Q (medicines beginning with Q) R (medicines beginning with R) S (medicines beginning with S) T (medicines beginning with T) U (medicines beginning with U) V (medicines beginning with V) W (medicines beginning with W) X (medicines beginning with X) Y (medicines beginning with Y) Z (medicines beginning with Z)

Medicines beginning with T

Trifluoperazine

Trifluoperazine 1mg tablets

No stability information

Stability notes for Trifluoperazine 1mg tablets

There are no stability notes for this medicine.

Suppliers

Trifluoperazine 1mg tablets (Advanz Pharma)
Trifluoperazine 1mg tablets (Alliance Healthcare (Distribution) Ltd)
Trifluoperazine 1mg tablets (Morningside Healthcare Ltd)

Trifluoperazine 5mg tablets

No stability information

Stability notes for Trifluoperazine 5mg tablets

There are no stability notes for this medicine.

Suppliers

Trifluoperazine 5mg tablets (Advanz Pharma)
Trifluoperazine 5mg tablets (Alliance Healthcare (Distribution) Ltd)
Trifluoperazine 5mg tablets (Morningside Healthcare Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.